Improved olfactory function following high-frequency transcutaneous auricular vagal nerve stimulation in post-COVID-19 patients with olfactory dysfunction

高频经皮耳迷走神经刺激可改善新冠肺炎后嗅觉功能障碍患者的嗅觉功能

阅读:2

Abstract

PURPOSE: Previous studies in healthy individuals showed that high-frequency but not the low frequency non-invasive vagal nerve stimulation improves olfactory function in healthy individuals. The present study aimed to analyze the potential effects of non-invasive, high-frequency transcutaneous auricular vagal nerve stimulation (TA-VNS) on olfactory function in patients with olfactory dysfunction (OD) and healthy individuals. METHODS: Patients with post-COVID-19 associated OD (n = 10) and normosmic individuals (n = 30) performed olfactory testing (Sniffin` Sticks), trigeminal testing (lateralization test), attentional tests (d2 test), ratings of odor intensity and pleasantness before and after receiving a TA-VNS for 10 min. Patients with OD received only TA-VNS while normosmic subjects underwent, in addition to TA-VNS, placebo stimulation (control condition) with electrode placement of TA-VNS, and active-control transcutaneous stimulation at the forearm in a randomized order with a minimum 24-h interval between sessions. RESULTS: In patients with OD intensity ratings for fish and pleasantness ratings for eucalyptol increased and olfactory discrimination improved (p = 0.017) as opposed to olfactory threshold (p = 0.18). For both, patients with OD and healthy individuals results of the d2 attention test improved following the TA-VNS. In healthy individuals, there were no differences in olfactory discrimination nor threshold regarding the 3 stimulation modalities (TA-VNS, placebo (control condition), transcutaneous stimulation). CONCLUSION: These results seem to underline the functional connection of the olfactory system with the afferent vagus network. However, a ceiling effect for olfactory discrimination did not allow to observe a possible improvement in normosmic individuals. Further studies in patients with OD are needed to characterize this potential therapeutic effect of TA-VNS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。